Clinicopathologic features of myositis patients with CD8-MHC-1 complex pathology

Conclusions: CD8-MHC-1 complex is present in patients with PM, IBM, or unclassifiable group. The data may serve as an argument for a trial of immunosuppressive treatment in p62-immunonegative patients with unclassifiable myositis.

http://www.neurology.org/cgi/content/short/89/10/1060?rss=1

Source: Neurology - September 4, 2017 Category: Neurology Authors: Ikenaga, C., Kubota, A., Kadoya, M., Taira, K., Uchio, N., Hida, A., Maeda, M. H., Nagashima, Y., Ishiura, H., Kaida, K., Goto, J., Tsuji, S., Shimizu, J. Tags: Muscle disease ARTICLE Source Type: research